In contrast with AD-Null or AD-GFP-PTM, the tumor cells in AD-p53PTM-E7-11 group manifested a remarkable decrease in immunofluorescence of proliferative biomarker ki67 (Figure 4E). Here, MKI67 is linked to neoplasm.